Markus Radsak

25PUBLICATIONS

109CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Learning, motivation and emotionTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 03, 2026

Type I interferon-activated NK cells control polycythemia vera in vivo.

|Mar 18, 2026

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Markus Meyerhöfer, Yawen Zhou, Aaron Gallego-Crespo

|Mar 05, 2026

Characterization of the TREM-1 signaling landscape in human neutrophils.

Frederic Ries, Matthias Klein, Nora Rogmann

|Jan 12, 2026

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Andreas Burchert, Franck E Nicolini, Philipp le Coutre

|Jan 06, 2026

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Hartmut Döhner, Daniela Späth, Maral Saadati

|Feb 12, 2025

Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort.

Mareike Tometten, Fabian Beier, Martin Kirschner

Pageof 5

Frequent Collaborators

Federico Marini

Felix Melchior

Tobias Bopp

Daniel Sasca

Hans Christian Probst

Markus Bosmann

Katharina S Götze

Matthias Mack

Monika Hartmann

Borhane Guezguez

Frequent Collaborators

Federico Marini

Felix Melchior

Tobias Bopp

Daniel Sasca